MANAGING CYTOKINE RELEASE SYNDROME (CRS) AND NEUROTOXICITY WITH STEP-UP DOSING OF MOSUNETUZUMAB IN RELAPSED/REFRACTORY (R/R) B-CELL NON-HODGKIN LYMPHOMA (NHL)

2019 ◽  
Vol 37 ◽  
pp. 310-311
Author(s):  
L.H. Sehn ◽  
S. Assouline ◽  
N.L. Bartlett ◽  
F. Bosch ◽  
C.M. Diefenbach ◽  
...  
Keyword(s):  
B Cell ◽  
Hodgkin Lymphoma ◽  
Cytokine Release ◽  
Cytokine Release Syndrome ◽  
Non Hodgkin Lymphoma

Managing Cytokine Release Syndrome and Neurotoxicity with Step-Up Dosing of Mosunetuzumab in Relapsed/Refractory B-Cell Non-Hodgkin Lymphoma

2019 ◽  
Vol 19 ◽  
pp. S247
Author(s):  
Nancy L. Bartlett ◽  
Laurie H. Sehn ◽  
Sarit Assouline ◽  
Francesc Bosch ◽  
Catherine M. Diefenbach ◽  
...  
Keyword(s):  
B Cell ◽  
Hodgkin Lymphoma ◽  
Cytokine Release ◽  
Cytokine Release Syndrome ◽  
Non Hodgkin Lymphoma

scholarly journals The model of cytokine release syndrome in CAR T-cell treatment for B-cell non-Hodgkin lymphoma

2020 ◽  
Vol 5 (1) ◽  
Author(s):  
Jianshu Wei ◽  
Yang Liu ◽  
Chunmeng Wang ◽  
Yajing Zhang ◽  
Chuan Tong ◽  
...  
Keyword(s):  
T Cell ◽  
B Cell ◽  
Hodgkin Lymphoma ◽  
Cytokine Release ◽  
Cytokine Release Syndrome ◽  
Car T Cell ◽  
Non Hodgkin Lymphoma ◽  
Car T
Sign in / Sign up

Export Citation Format

Share Document